{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:51:14Z","timestamp":1740138674570,"version":"3.37.3"},"reference-count":43,"publisher":"Informa UK Limited","issue":"3","funder":[{"DOI":"10.13039\/501100004726","name":"Ministry of Health, Welfare and Sport","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004726","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004726","name":"Ministry of Health, Welfare and Sport","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004726","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2024,3,3]]},"DOI":"10.1080\/14740338.2023.2267971","type":"journal-article","created":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T17:59:43Z","timestamp":1696528783000},"page":"323-331","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["The role of co-morbidities in the development of an AEFI after COVID-19 vaccination in a large prospective cohort with patient-reported outcomes in the Netherlands"],"prefix":"10.1080","volume":"23","author":[{"given":"C.","family":"Ouaddouh","sequence":"first","affiliation":[{"name":"Vaccine Team, Netherlands Pharmacovigilance Centre Lareb, \u2018s-Hertogenbosch, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9197-9079","authenticated-orcid":false,"given":"J.W.","family":"Duijster","sequence":"additional","affiliation":[{"name":"Vaccine Team, Netherlands Pharmacovigilance Centre Lareb, \u2018s-Hertogenbosch, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Lieber","sequence":"additional","affiliation":[{"name":"Vaccine Team, Netherlands Pharmacovigilance Centre Lareb, \u2018s-Hertogenbosch, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8965-3224","authenticated-orcid":false,"given":"F.P.A.M.","family":"van Hunsel","sequence":"additional","affiliation":[{"name":"Vaccine Team, Netherlands Pharmacovigilance Centre Lareb, \u2018s-Hertogenbosch, Netherlands"},{"name":"Faculty of Science and Engineering, FarmacoTherapie, Epidemiologie en Economie Groningen Research Institute of Pharmacy, Groningen, the Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,10,11]]},"reference":[{"key":"e_1_3_7_2_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10081363"},{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.3947\/ic.2021.0302"},{"key":"e_1_3_7_4_1","unstructured":"European Medicines Agency (EMA). Consideration on core requirements for RMPs of COVID-19 vaccines - coreRMP19 guidance v3.1. vol. EMA\/PRAC\/709308\/2022. 2022."},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9050435"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2009.05.005"},{"key":"e_1_3_7_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002936"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2009.196"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-022-02310-7"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2022.2136435"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.04.026"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000003983"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10040834"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2022.03.005"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1078736"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.01.013"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-022-01151-w"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-023-01281-9"},{"key":"e_1_3_7_19_1","unstructured":"Medical Dictionary for Regulatory Activities. Available from: https:\/\/www.meddra.org\/"},{"key":"e_1_3_7_20_1","volume-title":"Advances in patient safety: from research to implementation (volume 2: concepts and methodology)","author":"Kohl KS","year":"2005","unstructured":"Kohl KS, Bonhoeffer J, Braun MM, et al. The Brighton Collaboration. The brighton collaboration: creating a global standard for case definitions (and guidelines) for adverse events following immunization. In: Henriksen K, Battles JB, Marks ES, et al., editors. Advances in patient safety: from research to implementation (volume 2: concepts and methodology). Rockville (MD): Agency for Healthcare Research and Quality (US); 2005. Feb. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK20507\/"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.876336"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108906"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00224-3"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10040566"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-023-15118-8"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.1159\/000519853"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2021.100273"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-020-00946-z"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2023.2134344"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2015.15020152"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.1177\/1745691621989243"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.60.10.1009"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis1208"},{"key":"e_1_3_7_34_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.940357"},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155412"},{"key":"e_1_3_7_36_1","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.102982"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2021.404"},{"key":"e_1_3_7_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-022-01968-y"},{"key":"e_1_3_7_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14774"},{"key":"e_1_3_7_40_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-023-01059-0"},{"key":"e_1_3_7_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-021-05017-9"},{"key":"e_1_3_7_42_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11030687"},{"key":"e_1_3_7_43_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-021-02674-w"},{"key":"e_1_3_7_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102984"}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14740338.2023.2267971","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T10:41:54Z","timestamp":1709808114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14740338.2023.2267971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,11]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3,3]]}},"alternative-id":["10.1080\/14740338.2023.2267971"],"URL":"https:\/\/doi.org\/10.1080\/14740338.2023.2267971","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"type":"print","value":"1474-0338"},{"type":"electronic","value":"1744-764X"}],"subject":[],"published":{"date-parts":[[2023,10,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieds20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-06-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-25","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}